Jump Financial’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$344K Buy
98,600
+17,329
+21% +$62.4K ﹤0.01% 1420
2025
Q4
$278K Sell
81,271
-594,329
-88% -$2.65M ﹤0.01% 1594
2025
Q3
$3.4M Buy
+675,600
New +$2.98M 0.04% 531
2024
Q2
Sell
-221,913
Closed -$1.01M 1744
2024
Q1
$1.01M Sell
221,913
-25,684
-10% -$131K 0.03% 804
2023
Q4
$1.41M Sell
247,597
-26,905
-10% -$125K 0.05% 533
2023
Q3
$1.26M Sell
274,502
-107,124
-28% -$652K 0.05% 563
2023
Q2
$2.47M Buy
381,626
+289,626
+315% +$1.98M 0.09% 314
2023
Q1
$694K Buy
+92,000
New +$835K 0.03% 757
2022
Q4
Sell
-230,400
Closed -$2.28M 1518
2022
Q3
$2.28M Sell
230,400
-42,212
-15% -$463K 0.09% 339
2022
Q2
$2.9M Buy
272,612
+23,712
+10% +$201K 0.12% 222
2022
Q1
$2.43M Buy
248,900
+194,800
+360% +$1.84M 0.1% 240
2021
Q4
$774K Buy
54,100
+13,553
+33% +$206K 0.05% 481
2021
Q3
$813K Sell
40,547
-76,253
-65% -$1.35M 0.06% 345
2021
Q2
$2.57M Buy
+116,800
New +$3.22M 0.25% 69

Other funds holding ABCL